Challenges around data are mostly around data itself, particularly if it is not timely, says Lee A. Norman, MD, MHS, MBA, the senior medical director for Optum Care Kansas City.
The data used in clinical decision-making needs to be as real time as possible, said Lee A. Norman, MD, MHS, MBA, who appeared at The American Journal of Managed Care®’s Institute for Value-Based Medicine® event on population health in Kansas City, Missouri. He served as the secretary of the Kansas Department of Health and Environment from 2019 to 2021 under Governor Laura Kelly. Norman, who also served in the US Air Force and later as a colonel in the Kansas Army National Guard, is currently senior medical director for Optum Care Kansas City.
Transcript
What are some of the challenges to implementing data in health care practices improve patient care?
The challenges are mostly around data itself, which is, do we have the quality of data and is it timely? I can remember back in the olden days, let's say in the mid-80s, where we signed up to take care of patients and HMO [health management organization] plans, and we didn't have any data as the month would go along. And then all of a sudden, at the end of the year, we'd find out how we did, both in terms of clinical data and in terms of financial performance. That's not adequate. Those plans went bye-bye.
What is really necessary now is data that's almost as real time as possible and [that can] help us to understand where are we strong? Where are we weak? How does this patient fare in this value-based world compared to the fee-for-service world? There shouldn't be a whole vast difference between those worlds as it relates to patient outcomes. But it's very critical, and it always has been, but we're getting better at it, to have data at our fingertips to make good clinical decision-making.
For Patients Who Cannot Wait, This Off-the-Shelf CAR NK Treatment for AML Leaves Healthy Cells Alone
May 12th 2025First part of a 2-part interview with Stephen Strickland, MD, MSCI, director of leukemia research for Sarah Cannon Research Institute. Strickland recently presented data from a phase 1 trial of SENTI-202, an investigational chimeric antigen receptor (CAR) natural killer (NK) cell therapy.
Read More
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Black Youths Overlabeled High Risk in Mental Health Emergencies
May 9th 2025Despite similar scores on an aggression risk evaluation tool in a pediatric emergency department, Black youths were significantly more likely to be labeled with a high aggression risk behavioral health flag in their electronic health records compared with White youths.
Read More
NCCN Summit Seeks to Build Better Connections Between Oncology and Primary Care
May 7th 2025The National Comprehensive Cancer Network (NCCN) policy summit highlighted the need for improved communication between oncology and primary care to enhance cancer survivor outcomes and care transitions.
Read More